Transition from Clinical Trials to RWE in Psoriasis & Step in to the possibility in Alopecia Areata

Introduction

Take This Event

eP2P – Virtual
on Transition from Clinical Trials to RWE in Psoriasis & Step in to the possibility in Alopecia Areata to be presented by Dr. Sahal Samarkandy & Dr. Fares Alkhayal whole session will be chaired by Dr. Osama AlSharif

Objectives

1. Discuss how real-world experience shapes clinical practice and informs practical treatment decision-making.
2. Highlight how real-world experiences with ixekizumab in patients with plaque psoriasis (PsO) compare with data from randomized controlled trials, and address knowledge gaps
3. Highlight how Highlight how real-world experiences with
baricitinib in patients with Alopecia Areata (AA) compare with data from randomized controlled trials, and address knowledge gaps

Speaker

Fares Alkhayal, MD, ACDF

Advance Clinical Dermatology Consultant
Prince Sultan Military Medical City, Riyadh

Dr Sahal Samarkandy

Assistant Professor and RTP Director
Dermatology Consultant - Ministry of National Guard Health Affairs
and King Saud Bin Abdulaziz University for Health Sciences.
Saudi and Arab board of Dermatology
Former fellow of laser and surgical dermatology from Univesity of Miam

Dr. Osama Al Sharif

Dermatology/Pediatric Consultant
King Fahad Hospital Medina, Saudi Arabia.
Saudi Board of Dermatology and Venerology, Riyadh KSA